Cargando…

Cytokine adsorption and ECMO in patients with COVID-19 – Author's reply

Detalles Bibliográficos
Autor principal:	Supady, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260101/ https://www.ncbi.nlm.nih.gov/pubmed/34242580 http://dx.doi.org/10.1016/S2213-2600(21)00274-5

Ejemplares similares

Cytokine adsorption and ECMO in patients with COVID-19
por: Rybalko, Andrey, et al.
Publicado: (2021)

Cytokine adsorption and ECMO in patients with COVID-19
por: Nardelli, Pasquale, et al.
Publicado: (2021)

ECMO support for COVID-19: a balancing act – Authors' reply
por: Barbaro, Ryan P, et al.
Publicado: (2021)

Determinants of long-term outcomes in patients with COVID-19 supported with ECMO – Authors' reply
por: Lorusso, Roberto, et al.
Publicado: (2023)

Cytokine Adsorption in Critically Ill Patients Requiring ECMO Support
por: Lother, Achim, et al.
Publicado: (2019)

Comment on: Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO: the CytoSorb therapy in COVID‑19 (CTC) registry
por: Supady, A., et al.
Publicado: (2023)

Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? Authors' response
por: Supady, Alexander, et al.
Publicado: (2021)

COVID-19 in patients with HIV – Authors' reply
por: Miró, José M, et al.
Publicado: (2020)

Intravenous anakinra for cytokine storm syndromes – Authors' reply
por: Mehta, Puja, et al.
Publicado: (2020)

Cancer and COVID-19 – Authors' reply
por: Kuderer, Nicole M, et al.
Publicado: (2020)

Remdesivir and COVID-19 – Authors' reply
por: Wang, Yeming, et al.
Publicado: (2020)

Frailty and mortality in patients with COVID-19 – Authors' reply
por: McCarthy, Kathryn, et al.
Publicado: (2020)

Management of diabetes in patients with COVID-19 – Authors' reply
por: Bornstein, Stefan R, et al.
Publicado: (2020)

Cytokine adsorption during ECMO for COVID-19-related ARDS
por: Shekar, Kiran, et al.
Publicado: (2021)

COVID-19 and preterm birth – Authors' reply
por: Choudhary, Rahul, et al.
Publicado: (2021)

Neuropsychiatric disorders and COVID-19 – Authors' reply
por: Taquet, Maxime, et al.
Publicado: (2021)

COVID-19 and myocardial infarction – Authors' reply
por: Katsoularis, Ioannis, et al.
Publicado: (2021)

COVID-19 research in LMICs – Authors' reply
por: Torres, Irene, et al.
Publicado: (2021)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Fluvoxamine for the treatment of COVID-19 – Author's reply
por: Reis, Gilmar, et al.
Publicado: (2022)

Mavrilimumab for severe COVID-19 – Authors' reply
por: De Luca, Giacomo, et al.
Publicado: (2020)

Characterising neuropsychiatric disorders in patients with COVID-19 – Authors' reply
por: Varatharaj, Aravinthan, et al.
Publicado: (2020)

Dapagliflozin in patients with COVID-19: mind the kidneys – Authors' reply
por: Kosiborod, Mikhail N, et al.
Publicado: (2022)

Cortisol concentrations and mortality from COVID-19 – Authors' reply
por: Tan, Tricia, et al.
Publicado: (2020)

COVID-19: from hospitals to courts – Author's reply
por: Usuelli, Michele
Publicado: (2021)

Azithromycin for mild-to-moderate COVID-19 – Authors' reply
por: Hinks, Timothy S C
Publicado: (2021)

Antipsychotics and COVID-19: the debate goes on – Authors' reply
por: De Picker, Livia, et al.
Publicado: (2021)

WHO COVID-19 therapeutic guidelines – Authors' reply
por: White, Nicholas J, et al.
Publicado: (2021)

COVID-19 and global mental health – Authors' reply
por: Kola, Lola, et al.
Publicado: (2021)

COVID-19 and maternal and perinatal outcomes – Authors' reply
por: Chmielewska, Barbara, et al.
Publicado: (2021)

Combining immunomodulators and antivirals for COVID-19 – Authors' reply
por: Almansa, Raquel, et al.
Publicado: (2021)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19 – Authors' reply
por: Hayem, Gilles, et al.
Publicado: (2020)

Psychiatric and neuropsychiatric syndromes and COVID-19 – Authors' reply
por: Rogers, Jonathan P, et al.
Publicado: (2020)

Surgery during the COVID-19 pandemic – Authors' reply
por: COVIDSurg Collaborative
Publicado: (2020)

Depression and anxiety during COVID-19 – Authors' reply
por: Santomauro, Damian F, et al.
Publicado: (2022)

Efficacy matters: broadening complement inhibition in COVID-19 – Authors' reply
por: Vlaar, Alexander P J, et al.
Publicado: (2021)

Seeking clarity on retinal findings in patients with COVID-19 – Authors' reply
por: Marinho, Paula M, et al.
Publicado: (2020)

Authors' Reply
por: Zhen, Wei, et al.
Publicado: (2021)

Authors’ Reply
por: Pramanik, Raja, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8kfj70bpvk73tcfm109f9gsjkn